NASDAQ / LIVE COMPANY INTELLIGENCE

Gelteq Limited

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERGELS
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / GELS COVERAGE

What’s moving Gelteq Limited now

Current reporting with the operating signal separated from the noise.

01
Gelteq Limited: Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

Gelteq Limited: Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

The development tests whether Gelteq Limited can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
02
Gelteq Limited: Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform

Gelteq Limited: Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform

The story matters when it changes Gelteq Limited’s customers, execution, competitive position or capital requirements.

Watch next: official volume, pricing, inventory and segment margin.
03
Gelteq Limited Expands U.S. Commercial Strategy Through Exclusive Logistics Agreement with Healthy Extracts Inc.

Gelteq Limited Expands U.S. Commercial Strategy Through Exclusive Logistics Agreement with Healthy Extracts Inc.

The story matters when it changes Gelteq Limited’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Gelteq Limited Receives FDA Approval for Suitability Petition on New Animal Drug Development

Gelteq Limited Receives FDA Approval for Suitability Petition on New Animal Drug Development

The story matters when it changes Gelteq Limited’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Gelteq Limited Prices US$5.2 Million Initial Public Offering

Gelteq Limited Prices US$5.2 Million Initial Public Offering

The story matters when it changes Gelteq Limited’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
Gelteq Limited

Gelteq Limited

The story matters when it changes Gelteq Limited’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest GELS filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

6-KOfficial SEC filingFiled 2026-07-06 · Period 2026-07-02SEC ↗6-KOfficial SEC filingFiled 2026-06-30 · Period 2025-12-31SEC ↗6-KOfficial SEC filingFiled 2026-06-02 · Period 2026-06-02SEC ↗6-KOfficial SEC filingFiled 2026-05-26 · Period 2026-05-26SEC ↗6-KOfficial SEC filingFiled 2026-03-24 · Period 2026-03-24SEC ↗3Official SEC filingFiled 2026-03-18 · Period 2026-03-18SEC ↗3Official SEC filingFiled 2026-03-18 · Period 2026-03-18SEC ↗3Official SEC filingFiled 2026-03-18 · Period 2026-03-18SEC ↗
EARNINGS / QUARTERLY TRACKER

Gelteq Limited, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.